Company Lucid Diagnostics Inc.
Equities
LUCD
US54948X1090
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.652 USD | -4.55% | -19.27% | -54.26% |
Mar. 27 | Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating | MT |
Mar. 26 | Transcript : Lucid Diagnostics Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
Business Summary
Number of employees: 70
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Diagnostics Technology
100.0
%
| 0 | 100.0 % | 2 | 100.0 % | +544.03% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 2 | 100.0 % | +544.03% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lishan Aklog
CEO | Chief Executive Officer | 58 | 18-05-07 |
Shaun O’Neil
PSD | President | 42 | 18-06-30 |
Dennis McGrath
DFI | Director of Finance/CFO | 67 | 18-05-07 |
Suman M. Verma
CTO | Chief Tech/Sci/R&D Officer | - | 21-10-20 |
Brian deGuzman
CMP | Compliance Officer | 60 | - |
Michael Parks
IRC | Investor Relations Contact | - | 22-12-31 |
Michael Gordon
LAW | General Counsel | 50 | 22-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
James Cox
BRD | Director/Board Member | 81 | 18-05-07 |
Jacque Sokolov
BRD | Director/Board Member | 69 | 21-04-28 |
Stanley Lapidus
BRD | Director/Board Member | 75 | 21-07-27 |
Dennis McGrath
DFI | Director of Finance/CFO | 67 | 18-05-07 |
Ronald Sparks
BRD | Director/Board Member | 69 | 21-09-30 |
Debra White
BRD | Director/Board Member | 62 | 22-07-31 |
Lishan Aklog
CEO | Chief Executive Officer | 58 | 18-05-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 5,000 | 0 | 0 | 29.61 % |
Stock B | 1 | 48,244,798 | 14,286,216 ( 29.61 %) | 0 | |
Stock C | 0 | 13,625 | 0 | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-54.26% | 32.96M | |
+72.94% | 12.34B | |
-18.31% | 7.98B | |
+15.24% | 7.19B | |
+2.18% | 5.81B | |
+6.51% | 5.04B | |
+21.99% | 4.31B | |
-20.27% | 4.03B | |
-41.44% | 2.21B | |
+0.87% | 1.99B |
- Stock Market
- Equities
- LUCD Stock
- Company Lucid Diagnostics Inc.